Which institution has conducted India’s first-in-human gene therapy trial for Haemophilia?

Question

Institute for Stem Cell Science and Regenerative Medicine (BRIC-inStem), Bengaluru has successfully conducted India\'s first-in-human gene therapy trial for Haemophilia in collaboration with CMC Vellore.  Gene therapy is a biomedical technique that modifies or replaces faulty genes to treat or prevent diseases.  The aim is to introduce a functional gene to replace a mutated or disease-causing gene. Haemophilia is a rare genetic bleeding disorder due to mutations in genes on the X chromosome, affecting 1 in 10,000 people, especially males. BRIC-inStem is part of the Biotechnology Research and Innovation Council (BRIC).  It integrates 14 autonomous research institutions across India under one national umbrella.

GKToday Admin · Accepted Answer

Institute for Stem Cell Science and Regenerative Medicine (BRIC-inStem), Bengaluru Institute for Stem Cell Science and Regenerative Medicine (BRIC-inStem), Bengaluru has successfully conducted India\'s first-in-human gene therapy trial for Haemophilia in collaboration with CMC Vellore.  Gene therapy is a biomedical technique that modifies or replaces faulty genes to treat or prevent diseases.  The aim is to introduce a functional gene to replace a mutated or disease-causing gene. Haemophilia is a rare genetic bleeding disorder due to mutations in genes on the X chromosome, affecting 1 in 10,000 people, especially males. BRIC-inStem is part of the Biotechnology Research and Innovation Council (BRIC).  It integrates 14 autonomous research institutions across India under one national umbrella.

Current Affairs

Daily MCQs

Monthly MCQs

Topic Wise CA MCQs

CA MCQs in Other Languages

GK MCQs Section

SSC/RRB/States Level MCQs